Several important updates: Natural Immunity, Vitamin D and Ivermectin
Good news on all three fronts
For those of you who want to stay up to date on important pandemic subjects, here are brief reports with links to newly published medical studies. All three address subjects that I have emphasized in my writings and are critically important to safeguard your health.
Natural Immunity Should be Counted Equivalent to Vaccine Immnunity
A new article from the CDC has attracted attention because careful analysis shows that natural immunity from prior infection can be better than vaccine immunity. This study found this during the time when the delta variant was dominant.
Though CDC does not explicitly say this, this is the truth: The study shows that those who have recovered from COVID-19 have more protection against infections from DELTA than those who have only been vaccinated.
Researchers reviewed data from California and New York from May to November 2021, when the delta variant was dominant in the U.S.
Four groups of people were analyzed 1) unvaccinated with no prior COVID-19 infection, 2) vaccinated with no prior infection, 3) unvaccinated who recovered from COVID-19, and 4) vaccinated who recovered.
By the first week of October, COVID-19 rates among the vaccinated with no previous infection were 6.2 times lower in California and 4.5 times lower in New York than among the unvaccinated with no previous infection.
However, among the unvaccinated with a previous infection, the COVID-19 rate was 29 times lower in California and 14.7 times lower in New York.
For many observations by several experts see this article For example, Dr. Marty Makary said: “The data are now abundantly clear. Natural immunity is more effective than vaccine immunity. Sadly, tens of thousands Americans lost their job & livelihood because the antibodies circulating in their blood are antibodies the govt does not recognize.”
Similarly, David Asman said: “How many times was this denied by “experts.” And how many fired nurses, police, fire fighters, Marines, etc, whose natural immunity was superior to the vaccinated deserve to be reinstated!”
Dr. Monica Gandhi said: “this large US analysis shows immunity from prior infection >> vaccine-induced immunity to protect against re-infection/hospitalization with Delta. In U.S. recovery should count as “fully immune” (or “fully vaccinated”).”
Dr. Andrew Bostom said: “When looking at the summer & fall of 2021, when delta became dominant in this country surviving a previous infection now provided greater protection against subsequent infection than vaccination”
Dr. Jay Bhattacharya said: “The CDC starts to acknowledge reality, one piece at a time. What excuse is there now to not consider prior infection in vaccine mandates?”
Vitamin D is a must use supplement
A new study has reaffirmed the very positive benefits of vitamin D for fighting COVID. I have covered this topic in a previous article.
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes
This was found: “we also found a significant association between vitamin D status and the risk of SARS-CoV-2 infection and hospitalization. Taken together our results indicate that 25OHD is a marker of COVID-19 in-hospital severity and suggest that a good vitamin D status might have a protective role on COVID-19 clinical outcomes and even decrease the risk of becoming infected by SARS-CoV-2.”
Additionally, “this meta-analysis shows that at hospital admission COVID-19 patients with either vitamin D insufficiency or deficiency (including severe deficiency) present an increased risk of respiratory distress and death from respiratory failure or other complications. Moreover, subjects with a suboptimal vitamin D status seem at higher risk of SARS-CoV-2 infection, as suggested by a previous meta-analysi and of COVID-19 related hospitalization.”
Ivermectin: positive results keep rolling in
Of special importance is that NIH in its new COVID treatment guidelines covered in a previous article has ignored a recent detailed study of ivermectin and aimed at informing clinical guidelines reached these conclusions: “…large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.”
An even newer study found remarkable benefits of using IVM, including a 68% reduction in mortality and 56% reduction in hospitalization. NIH is not respecting positive results for IVM. And their guidelines could make it difficult for states trying to make IVM easily available.
Bonus: Here is a recent podcast with me on a show run by two physicians:
